Repotrectinib companion diagnostic - Almac Diagnostic Services
Alternative Names: Next-generation sequencing assay - Almac Diagnostic ServicesLatest Information Update: 22 Aug 2022
At a glance
- Originator Almac Diagnostic Services
- Developer Almac Diagnostic Services; Turning Point Therapeutics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours